New Methods Show
Promise for Rehabilitating Paralyzed Patients with Spinal Cord Injury
In the United States there are approximately 1,275,000
people currently living with paralysis caused by traumatic spinal cord injury
(SCI). Annually that number increases by 12,000 people. SCIs are caused from
mechanisms such as car accidents, sports, falls and violence. In a matter of
seconds a human life can drastically change for the worse. People coping with
paralysis may become dependent on a wheelchair due to a loss of sensation and
function of their arms and legs. They may lose bladder, bowel and sexual
function. In cases where the cervical region of the spinal cord is damaged
people may lose function of the diaphragm, becoming reliant on a ventilator to help
them breathe. Spinal cord injuries significantly alter quality of life.
Researchers dedicate their careers to restoring neural function of
physiological systems after an SCI.
Currently and in the future, techniques are being developed
to improve quality of life and return spinal cord function to patients. Some of
these techniques are robotics, functional electrical stimulation (FES),
epidural spinal stimulation (ESS), drugs and umbilical blood cell
transplantation.
Robotics
At the 2014 FIFA World Cup in Sao Paulo Brazil a paraplegic
man kicked the commencing ball, initiating the world class soccer competition.
The man was able to do this with the assistance of an Iron Man like robotic
exoskeleton developed by a faculty member at Duke named Miguel Nicolelis. The
suit was controlled with brain cues which translated into locomotion. Nicolelis
was assisted by 150 scientists from around the world.
Functional Electrode Stimulation
In FES, small pulses are delivered from an implanted device
to essentially bypass the disrupted spinal cord and stimulated down-stream
nerves to trigger muscle actions in the periphery. Patients triggering dormant
hand muscles to hold a can of soda is a basic example of this concept. Researchers
at Case Western Reserve University in Cleveland used this technique using an
external controller. Patients were able to stand and take steps on their own.
Researchers at Brown and the University of Pittsburgh have been developing a
way to internally stimulate body actions. Subjects have been able to control
robotic arms with their thoughts. With
more research, this method could be used to restore diaphragm and bladder
function.
Epidural Spinal
Stimulation
The University of UCLA and Pavlov Institute of Physiology in
Russia implanted devices directly on the surface of the lumbar spinal cord.
These devices were originally designed for pain management but when applied
daily and coupled with training, damaged nerves were repaired. In the study 4
paraplegic subjects were capable of voluntarily moving their leg muscles. Rob
Summers, a subject in the study claimed the treatment “completely changed” his
life. He was able to move his legs, his sexual function returned and he had the
capability to control his bladder and bowel without the assistance of the stimuli!
Drugs
Some first generation drugs have shown promise in SCI
treatment. Methylprednisolone has shown a 20% increase in motor and sensory
function if administered within 8 hours of injury. Monosialic Ganglioside has
been show to speed up SCI recovery if administered within 48 hours of injury.
Cell Transplantation
The China Spinal Cord Injury Network carried out a study
with 20 patients averaging 7 years since the SCI. Mononuclear cells, known to
have exceptional repair and restoration characteristics, were drawn from
umbilical blood. The cells were then transplanted above and below the injury
site. After the implantation, subjects participated in intense walking training
for 6 hours a day, 6 days a week for six months. At the end of the study 15-20
patients could walk at least 10 meters with minimal assistance. 12 of 20 were
able to stand, sit and go to the bathroom unassisted. With imaging neural
fibers could be seen spanning the injury site showing restoration of the spinal
cord.
Some prospective studies have been done in mice introducing
Schwann cells into the CNS but are still too early in human trials to draw any
conclusions about their efficacy.
While many of these techniques have promising futures, they
are expensive and exclusively available to research participants. With more
research and understanding of the mechanism in which each treatment works, cost
efficient techniques can be developed to help people with SCI live
independently once again.
To see the full article, check out this link: http://www.aaas.org/news/new-methods-show-promise-rehabilitating-paralyzed-patients-spinal-cord-injury
This is super interesting! It is amazing that so many different techniques are being researched for the same injury. I am curious to know which of these methods has shown the most promise so far. I was also interested to find out more about how the "brain controlled" robotics actually work, is this purely through electrical signals from the brain and if so, how do they get the signals from the neuron to the robot? Is there surgery involved with this or is it more similar to an EEG reading the impulses and then creating a secondary signal to cause movement? This article talks a little bit more about how those work! http://www.technologyreview.com/news/421347/robotic-limbs-that-plug-into-the-brain/
ReplyDeleteThe cell therapy is also very interesting, since we have been talking a lot about it in genetics!
This comment has been removed by the author.
ReplyDeleteThere is some exciting research for pain management of SCI patients currently in rat models. They have found that a neurtoxin called Acrolein is released after severe spinal nerve injury and up-regulates the number of TRPA-1 pain receptors in these neurons. The mechanism is still being worked out, but acrolein and TRPA-1 have been indicated as responsible for hyperalgesia (hyper sensitive to pain) in SCI patients. Additionally, this study is the first to link acrolein to the neuropathic pain that can occur in the periphery following SCI. Neuropathy can be difficult to treat, especially if it is SCI-induced neuropathy, and the upcoming research of TRPA-1 inhibitors for pain management of SCI could improve quality of life for many of these patients.
ReplyDeleteHere's the DOI and link to this article.
DOI: 10.1111/jnc.13352
http://onlinelibrary.wiley.com/doi/10.1111/jnc.13352/full
There is some exciting research for pain management of SCI patients currently in rat models. They have found that a neurtoxin called Acrolein is released after severe spinal nerve injury and up-regulates the number of TRPA-1 pain receptors in these neurons. The mechanism is still being worked out, but acrolein and TRPA-1 have been indicated as responsible for hyperalgesia (hyper sensitive to pain) in SCI patients. Additionally, this study is the first to link acrolein to the neuropathic pain that can occur in the periphery following SCI. Neuropathy can be difficult to treat, especially if it is SCI-induced neuropathy, and the upcoming research of TRPA-1 inhibitors for pain management of SCI could improve quality of life for many of these patients.
ReplyDeleteHere's the DOI and link to this article.
DOI: 10.1111/jnc.13352
http://onlinelibrary.wiley.com/doi/10.1111/jnc.13352/full